HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-AUG-18 5QIN TITLE TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6- TITLE 2 METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2- TITLE 3 YL}ACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 237-549; COMPND 5 SYNONYM: TGFR-2,TGF-BETA TYPE II RECEPTOR,TRANSFORMING GROWTH FACTOR- COMPND 6 BETA RECEPTOR TYPE II,TBETAR-II; COMPND 7 EC: 2.7.11.30; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGFBR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 4 06-MAR-24 5QIN 1 REMARK REVDAT 3 12-MAY-21 5QIN 1 LINK REVDAT 2 26-DEC-18 5QIN 1 JRNL REVDAT 1 31-OCT-18 5QIN 0 JRNL AUTH Y.ZHANG,Y.ZHAO,A.J.TEBBEN,S.SHERIFF,M.RUZANOV,M.P.FERESHTEH, JRNL AUTH 2 Y.FAN,J.LIPPY,J.SWANSON,C.P.HO,B.S.WAUTLET,A.ROSE,K.PARRISH, JRNL AUTH 3 Z.YANG,A.F.DONNELL,L.ZHANG,B.E.FINK,G.D.VITE, JRNL AUTH 4 K.AUGUSTINE-RAUCH,J.FARGNOLI,R.M.BORZILLERI JRNL TITL DISCOVERY OF 4-AZAINDOLE INHIBITORS OF TGF BETA RI AS JRNL TITL 2 IMMUNO-ONCOLOGY AGENTS. JRNL REF ACS MED CHEM LETT V. 9 1117 2018 JRNL REFN ISSN 1948-5875 JRNL PMID 30429955 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00357 REMARK 2 REMARK 2 RESOLUTION. 1.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 51413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2530 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.57 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.69 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3676 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2158 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3487 REMARK 3 BIN R VALUE (WORKING SET) : 0.2131 REMARK 3 BIN FREE R VALUE : 0.2670 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.14 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 189 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2275 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.70850 REMARK 3 B22 (A**2) : -0.11030 REMARK 3 B33 (A**2) : 2.81880 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.183 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.075 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.072 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.073 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.071 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2392 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3262 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 806 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 387 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2392 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 312 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2928 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.76 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.94 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5QIN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1001401996. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51988 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570 REMARK 200 RESOLUTION RANGE LOW (A) : 40.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03900 REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38700 REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3TZM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23%(W/V) PEG3350, 3%(V/V) GLCYEROL, PH REMARK 280 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.22500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.57000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.55500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.57000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.22500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.55500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 234 REMARK 465 HIS A 235 REMARK 465 MET A 236 REMARK 465 HIS A 237 REMARK 465 ASN A 238 REMARK 465 THR A 239 REMARK 465 ASN A 266 REMARK 465 THR A 267 REMARK 465 SER A 268 REMARK 465 GLU A 269 REMARK 465 GLN A 270 REMARK 465 SER A 416 REMARK 465 GLY A 417 REMARK 465 GLU A 542 REMARK 465 HIS A 543 REMARK 465 LEU A 544 REMARK 465 ASP A 545 REMARK 465 ARG A 546 REMARK 465 LEU A 547 REMARK 465 SER A 548 REMARK 465 GLY A 549 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 240 CG CD OE1 OE2 REMARK 470 GLU A 245 CG CD OE1 OE2 REMARK 470 LYS A 264 CG CD CE NZ REMARK 470 GLN A 265 CG CD OE1 NE2 REMARK 470 PHE A 271 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 272 CG CD OE1 OE2 REMARK 470 GLU A 316 CG CD OE1 OE2 REMARK 470 LEU A 317 CG CD1 CD2 REMARK 470 ARG A 348 NE CZ NH1 NH2 REMARK 470 ARG A 370 CG CD NE CZ NH1 NH2 REMARK 470 SER A 409 OG REMARK 470 VAL A 410 CG1 CG2 REMARK 470 ASP A 411 CG OD1 OD2 REMARK 470 ASP A 412 CG OD1 OD2 REMARK 470 ASN A 415 CG OD1 ND2 REMARK 470 GLU A 437 CD OE1 OE2 REMARK 470 GLU A 466 CD OE1 OE2 REMARK 470 LYS A 468 CE NZ REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 477 CD CE NZ REMARK 470 GLU A 480 CD OE1 OE2 REMARK 470 GLN A 508 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 308 -60.89 -102.13 REMARK 500 ARG A 378 -5.60 77.74 REMARK 500 ASP A 379 45.76 -152.89 REMARK 500 ASP A 397 63.56 70.13 REMARK 500 ALA A 414 33.20 -92.39 REMARK 500 LEU A 492 -64.44 -95.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 602 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 721 O REMARK 620 2 HOH A 742 O 87.5 REMARK 620 3 HOH A 749 O 90.4 95.6 REMARK 620 4 HOH A 755 O 174.1 90.2 95.3 REMARK 620 5 HOH A 914 O 90.4 177.6 83.2 91.9 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J2V A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 603 DBREF 5QIN A 237 549 UNP P37173 TGFR2_HUMAN 237 549 SEQADV 5QIN GLY A 234 UNP P37173 EXPRESSION TAG SEQADV 5QIN HIS A 235 UNP P37173 EXPRESSION TAG SEQADV 5QIN MET A 236 UNP P37173 EXPRESSION TAG SEQADV 5QIN ALA A 431 UNP P37173 GLU 431 ENGINEERED MUTATION SEQADV 5QIN ALA A 433 UNP P37173 ARG 433 ENGINEERED MUTATION SEQADV 5QIN ALA A 485 UNP P37173 GLU 485 ENGINEERED MUTATION SEQADV 5QIN ALA A 488 UNP P37173 LYS 488 ENGINEERED MUTATION SEQADV 5QIN ALA A 493 UNP P37173 ARG 493 ENGINEERED MUTATION SEQADV 5QIN ALA A 495 UNP P37173 ARG 495 ENGINEERED MUTATION SEQRES 1 A 316 GLY HIS MET HIS ASN THR GLU LEU LEU PRO ILE GLU LEU SEQRES 2 A 316 ASP THR LEU VAL GLY LYS GLY ARG PHE ALA GLU VAL TYR SEQRES 3 A 316 LYS ALA LYS LEU LYS GLN ASN THR SER GLU GLN PHE GLU SEQRES 4 A 316 THR VAL ALA VAL LYS ILE PHE PRO TYR GLU GLU TYR ALA SEQRES 5 A 316 SER TRP LYS THR GLU LYS ASP ILE PHE SER ASP ILE ASN SEQRES 6 A 316 LEU LYS HIS GLU ASN ILE LEU GLN PHE LEU THR ALA GLU SEQRES 7 A 316 GLU ARG LYS THR GLU LEU GLY LYS GLN TYR TRP LEU ILE SEQRES 8 A 316 THR ALA PHE HIS ALA LYS GLY ASN LEU GLN GLU TYR LEU SEQRES 9 A 316 THR ARG HIS VAL ILE SER TRP GLU ASP LEU ARG LYS LEU SEQRES 10 A 316 GLY SER SER LEU ALA ARG GLY ILE ALA HIS LEU HIS SER SEQRES 11 A 316 ASP HIS THR PRO CYS GLY ARG PRO LYS MET PRO ILE VAL SEQRES 12 A 316 HIS ARG ASP LEU LYS SER SER ASN ILE LEU VAL LYS ASN SEQRES 13 A 316 ASP LEU THR CYS CYS LEU CYS ASP PHE GLY LEU SER LEU SEQRES 14 A 316 ARG LEU ASP PRO THR LEU SER VAL ASP ASP LEU ALA ASN SEQRES 15 A 316 SER GLY GLN VAL GLY THR ALA ARG TYR MET ALA PRO GLU SEQRES 16 A 316 VAL LEU ALA SER ALA MET ASN LEU GLU ASN VAL GLU SER SEQRES 17 A 316 PHE LYS GLN THR ASP VAL TYR SER MET ALA LEU VAL LEU SEQRES 18 A 316 TRP GLU MET THR SER ARG CYS ASN ALA VAL GLY GLU VAL SEQRES 19 A 316 LYS ASP TYR GLU PRO PRO PHE GLY SER LYS VAL ARG GLU SEQRES 20 A 316 HIS PRO CYS VAL ALA SER MET ALA ASP ASN VAL LEU ALA SEQRES 21 A 316 ASP ALA GLY ARG PRO GLU ILE PRO SER PHE TRP LEU ASN SEQRES 22 A 316 HIS GLN GLY ILE GLN MET VAL CYS GLU THR LEU THR GLU SEQRES 23 A 316 CYS TRP ASP HIS ASP PRO GLU ALA ARG LEU THR ALA GLN SEQRES 24 A 316 CYS VAL ALA GLU ARG PHE SER GLU LEU GLU HIS LEU ASP SEQRES 25 A 316 ARG LEU SER GLY HET J2V A 601 44 HET MG A 602 1 HET GOL A 603 6 HETNAM J2V N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2- HETNAM 2 J2V B]PYRIDIN-2-YL]PYRIDIN-2-YL}ACETAMIDE HETNAM MG MAGNESIUM ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 J2V C20 H17 N5 O2 FORMUL 3 MG MG 2+ FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *218(H2 O) HELIX 1 AA1 GLU A 283 SER A 295 1 13 HELIX 2 AA2 ASN A 332 HIS A 340 1 9 HELIX 3 AA3 SER A 343 SER A 363 1 21 HELIX 4 AA4 LYS A 381 SER A 383 5 3 HELIX 5 AA5 SER A 409 ALA A 414 1 6 HELIX 6 AA6 THR A 421 MET A 425 5 5 HELIX 7 AA7 ALA A 426 ALA A 431 1 6 HELIX 8 AA8 VAL A 439 ARG A 460 1 22 HELIX 9 AA9 CYS A 461 GLY A 465 5 5 HELIX 10 AB1 CYS A 483 LEU A 492 1 10 HELIX 11 AB2 PRO A 501 ASN A 506 5 6 HELIX 12 AB3 HIS A 507 TRP A 521 1 15 HELIX 13 AB4 ASP A 524 ARG A 528 5 5 HELIX 14 AB5 THR A 530 GLU A 540 1 11 SHEET 1 AA1 5 ILE A 244 LYS A 252 0 SHEET 2 AA1 5 GLU A 257 LEU A 263 -1 O VAL A 258 N GLY A 251 SHEET 3 AA1 5 GLU A 272 PRO A 280 -1 O GLU A 272 N LEU A 263 SHEET 4 AA1 5 GLY A 318 ALA A 326 -1 O TYR A 321 N PHE A 279 SHEET 5 AA1 5 PHE A 307 THR A 315 -1 N GLU A 311 O TRP A 322 SHEET 1 AA2 2 ILE A 375 VAL A 376 0 SHEET 2 AA2 2 LEU A 402 ARG A 403 -1 O LEU A 402 N VAL A 376 SHEET 1 AA3 2 ILE A 385 VAL A 387 0 SHEET 2 AA3 2 CYS A 393 LEU A 395 -1 O CYS A 394 N LEU A 386 LINK MG MG A 602 O HOH A 721 1555 3645 2.00 LINK MG MG A 602 O HOH A 742 1555 1555 2.20 LINK MG MG A 602 O HOH A 749 1555 1555 1.99 LINK MG MG A 602 O HOH A 755 1555 1555 2.25 LINK MG MG A 602 O HOH A 914 1555 1555 2.13 SITE 1 AC1 18 VAL A 250 VAL A 258 ALA A 275 LYS A 277 SITE 2 AC1 18 PHE A 294 LEU A 305 LEU A 323 THR A 325 SITE 3 AC1 18 ALA A 326 PHE A 327 HIS A 328 ALA A 329 SITE 4 AC1 18 GLY A 331 LEU A 386 ASP A 397 HOH A 701 SITE 5 AC1 18 HOH A 839 HOH A 847 SITE 1 AC2 5 HOH A 721 HOH A 742 HOH A 749 HOH A 755 SITE 2 AC2 5 HOH A 914 SITE 1 AC3 6 ALA A 495 ARG A 497 TRP A 521 ASP A 522 SITE 2 AC3 6 HIS A 523 HOH A 715 CRYST1 64.450 75.110 75.140 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015516 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013314 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013308 0.00000